cc
Subject
Re: [R] R and clinical studies
Thank you to all those that responded to Delphine's original post on R and
clinical studies. They have provided much food for thought.
I had a couple of follow up questions/comments. Andrew is very correct in
pointing out that there are classes and workshops available for R. It's my
Thank you to all those that responded to Delphine's original post on R and
clinical studies. They have provided much food for thought.
I had a couple of follow up questions/comments. Andrew is very correct in
pointing out that there are classes and workshops available for R. It's my
[EMAIL PROTECTED] wrote:
Thank you to all those that responded to Delphine's original post on R and
clinical studies. They have provided much food for thought.
I had a couple of follow up questions/comments. Andrew is very correct in
pointing out that there are classes and workshops
A strength of R is that there is a wide variety of contribuitions to the
package, giving it great breadth.
A weakness of R is that there is a wide variety of contributers to the
package, some of whom spend a lot of time on the task of function correctness,
and some of whom spend little; some
Thank you to all those that responded to Delphine's original post on R and
clinical studies. They have provided much food for thought.
I had a couple of follow up questions/comments. Andrew is very correct in
pointing out that there are classes and workshops available for R. It's my
On Friday 16 March 2007 09:36, Delphine Fontaine wrote:
Thanks for your answer which was very helpfull. I have another question:
I have read in this document
(http://cran.r-project.org/doc/manuals/R-intro.pdf) that most of the
programs written in R are ephemeral and that new releases are not
/80175.
HTH,
-Mat
-Original Message-
From: [EMAIL PROTECTED]
[mailto:[EMAIL PROTECTED] On Behalf Of Delphine Fontaine
Sent: Friday, March 09, 2007 8:29 AM
To: r-help@stat.math.ethz.ch
Subject: [R] R and clinical studies
Does anyone know if for clinical studies the FDA would accept
Delphine Fontaine wrote:
Thanks for your answer which was very helpfull. I have another question:
I have read in this document
(http://cran.r-project.org/doc/manuals/R-intro.pdf) that most of the
programs written in R are ephemeral and that new releases are not
always compatible with
I agree that most problems arise in the data management / file derivation
phase. From my reading of 21 CFR 11, it appears that this document focuses
primarily on data management (as well as on software directly involved in a
medical device) rather than on validation of statistical functions. I
Does anyone know if for clinical studies the FDA would accept
statistical analyses performed with R ?
Delphine Fontaine
__
R-help@stat.math.ethz.ch mailing list
https://stat.ethz.ch/mailman/listinfo/r-help
PLEASE do read the posting guide
@stat.math.ethz.ch
Subject: [R] R and clinical studies
Does anyone know if for clinical studies the FDA would accept
statistical analyses performed with R ?
Delphine Fontaine
__
R-help@stat.math.ethz.ch mailing list
https://stat.ethz.ch/mailman/listinfo/r
12 matches
Mail list logo
